ACANYA

Peak

clindamycin phosphate and benzoyl peroxide

NDATOPICALGEL
Approved
Oct 2008
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
2

Mechanism of Action

12.1 Mechanisms of Action Clindamycin: Clindamycin is a lincosamide antibacterial [see ] . Benzoyl Peroxide: Benzoyl peroxide is an oxidizing agent with bactericidal and keratolytic effects but the precise mechanism of action is unknown. 12.3 Pharmacokinetics The systemic absorption of clindamycin…

Clinical Trials (2)

NCT03122457Phase 2Completed

Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide

Started Jan 2017
NCT01016977Phase 4Completed

A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris

Started Oct 2009
40 enrolled
Acne Vulgaris

Loss of Exclusivity

LOE Date
Aug 5, 2029
41 months away
Patent Expiry
Aug 5, 2029

Patent Records (5)

Patent #ExpiryTypeUse Code
9561208
Jun 3, 2029
Product
U-916
10220049
Jun 3, 2029
Product
U-916
10624918
Jun 3, 2029
U-916
10137142
Jun 3, 2029
Product
U-916
8663699
Jun 3, 2029
U-124